Literature DB >> 8618690

Acute type II myofiber atrophy in critical illness.

L Gutmann1, D Blumenthal, L Gutmann1, S S Schochet.   

Abstract

Two patients with acute onset of profound weakness and loss of muscle bulk during a critical illness had unusual histopathological changes of type II myofibers. Both patients had respiratory failure and prolonged neuromuscular blockade. High-dose steroids were used in only one case and atracurium in the other. Muscle biopsies at days 30 to 32 demonstrated widespread atrophy, basophilic cytoplasm, and vesicular nuclei, features suggestive of regeneration involving virtually all type II myofibers and sparing type I myofibers. This may be another variant or critical illness myopathy or a variation of the pathology during the course of illness.

Entities:  

Mesh:

Year:  1996        PMID: 8618690     DOI: 10.1212/wnl.46.3.819

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

Review 1.  [Intensive care unit-acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy].

Authors:  K Judemann; D Lunz; Y A Zausig; B M Graf; W Zink
Journal:  Anaesthesist       Date:  2011-10       Impact factor: 1.041

2.  Tongue weakness and somatosensory disturbance following oral endotracheal extubation.

Authors:  Han Su; Tzu-Yu Hsiao; Shih-Chi Ku; Tyng-Guey Wang; Jang-Jaer Lee; Wen-Chii Tzeng; Guan-Hua Huang; Cheryl Chia-Hui Chen
Journal:  Dysphagia       Date:  2015-02-08       Impact factor: 3.438

Review 3.  Critical illness neuromuscular disease: clinical, electrophysiological, and prognostic aspects.

Authors:  B Tabarki; A Coffiniéres; P Van Den Bergh; G Huault; P Landrieu; G Sébire
Journal:  Arch Dis Child       Date:  2002-02       Impact factor: 3.791

Review 4.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

5.  High dose methylprednisolone counteracts the negative effects of rocuronium on diaphragm function.

Authors:  Karen Maes; Dries Testelmans; Debby Thomas; Marc Decramer; Ghislaine Gayan-Ramirez
Journal:  Intensive Care Med       Date:  2011-08-18       Impact factor: 17.440

Review 6.  Long-Term Outcomes in Acute Respiratory Distress Syndrome: Epidemiology, Mechanisms, and Patient Evaluation.

Authors:  Jessica A Palakshappa; Jennifer T W Krall; Lanazha T Belfield; D Clark Files
Journal:  Crit Care Clin       Date:  2021-05-27       Impact factor: 3.879

7.  Infusions of rocuronium and cisatracurium exert different effects on rat diaphragm function.

Authors:  Dries Testelmans; Karen Maes; Patrick Wouters; Scott K Powers; Marc Decramer; Ghislaine Gayan-Ramirez
Journal:  Intensive Care Med       Date:  2007-03-15       Impact factor: 17.440

Review 8.  A conceptual framework: the early and late phases of skeletal muscle dysfunction in the acute respiratory distress syndrome.

Authors:  D Clark Files; Michael A Sanchez; Peter E Morris
Journal:  Crit Care       Date:  2015-07-02       Impact factor: 9.097

9.  RNA-seq and metabolomic analyses of Akt1-mediated muscle growth reveals regulation of regenerative pathways and changes in the muscle secretome.

Authors:  Chia-Ling Wu; Yoshinori Satomi; Kenneth Walsh
Journal:  BMC Genomics       Date:  2017-02-16       Impact factor: 3.969

Review 10.  Approach to neuromuscular disorders in the intensive care unit.

Authors:  Kenneth C Gorson
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.